KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Income from Non-Controlling Interests (2016 - 2023)

Historic Income from Non-Controlling Interests for Biogen (BIIB) over the last 13 years, with Q4 2023 value amounting to -$800000.0.

  • Biogen's Income from Non-Controlling Interests rose 1111.11% to -$800000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$800000.0, marking a year-over-year decrease of 36666.67%. This contributed to the annual value of $400000.0 for FY2023, which is 10046.89% up from last year.
  • As of Q4 2023, Biogen's Income from Non-Controlling Interests stood at -$800000.0, which was up 1111.11% from -$200000.0 recorded in Q3 2023.
  • Over the past 5 years, Biogen's Income from Non-Controlling Interests peaked at $577.0 million during Q2 2021, and registered a low of -$388.7 million during Q4 2021.
  • For the 4-year period, Biogen's Income from Non-Controlling Interests averaged around $9.2 million, with its median value being -$300000.0 (2020).
  • Data for Biogen's Income from Non-Controlling Interests shows a peak YoY increase of 79596.27% (in 2021) and a maximum YoY decrease of 12946666.67% (in 2021) over the last 5 years.
  • Quarter analysis of 4 years shows Biogen's Income from Non-Controlling Interests stood at -$300000.0 in 2020, then crashed by 129466.67% to -$388.7 million in 2021, then surged by 99.77% to -$900000.0 in 2022, then increased by 11.11% to -$800000.0 in 2023.
  • Its last three reported values are -$800000.0 in Q4 2023, -$200000.0 for Q3 2023, and $1.7 million during Q2 2023.